Noninvasive imaging of tumor burden and molecular pathways in mouse models of cancer

Cold Spring Harbor Protocols

Volumn 2015, Issue 2, 2015, Pages 135-144

  Wang, Yuchuan ^a,d   Tseng, Jen Chieh ^a   Sun, Yanping ^a   Beck, Andrew H ^b   Kung, Andrew L ^c  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c Department of Medicine   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ANIMAL IMAGING SYSTEM; ARTICLE; BIOLUMINESCENCE; CANCER CELL; CANCER DIAGNOSIS; CANCER MODEL; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; ECHOGRAPHY; FLUORESCENCE IMAGING; HUMAN; IMAGE QUALITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHARMACODYNAMICS; POSITRON EMISSION TOMOGRAPHY; RADIATION DOSE; RADIATION EXPOSURE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR GROWTH; TUMOR VOLUME; ANIMAL; DISEASE MODEL; MOUSE; NEOPLASMS; PATHOLOGY; PROCEDURES;

ANIMALIA;

ANIMALS; DIAGNOSTIC IMAGING; DISEASE MODELS, ANIMAL; MICE; NEOPLASMS;

EID: 84923788037     PISSN: 19403402     EISSN: 15596095     Source Type: Journal    
DOI: 10.1101/pdb.top069930     Document Type: Article

References (51)

1. Ayers GD, McKinley ET, Zhao P, Fritz JM, Metry RE, Deal BC, Adlerz KM, Coffey RJ, Manning HC. 2010. Volume of preclinical xenograft tumors is more accurately assessed by ultrasound imaging than manual caliper measurements. J Ultrasound Med 29: 891–901.
2. Barrett T, Brechbiel M, Bernardo M, Choyke PL. 2007. MRI of tumor angiogenesis. J Magn Reson Imaging 26: 235–249.
3. Basser PJ, Pajevic S, Pierpaoli C, Duda J, Aldroubi A. 2000. In vivo fiber tractography using DT-MRI data. Magn Reson Med 44: 625–632.
4. Bullitt E, Gerig G, Pizer SM, Lin W, Aylward SR. 2003. Measuring tortuosity of the intracerebral vasculature from MRA images. IEEE Trans Med Imaging 22: 1163–1171.
5. Chenevert TL, McKeever PE, Ross BD. 1997. Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging. Clin Cancer Res 3: 1457–1466.
6. Choy G, Choyke P, Libutti SK. 2003. Current advances in molecular imaging: Noninvasive in vivo bioluminescent and fluorescent optical imaging in cancer research. Mol Imaging 2: 303–312.
7. Contag CH, Contag PR, Mullins JI, Spilman SD, Stevenson DK, Benaron DA. 1995. Photonic detection of bacterial pathogens in living hosts. Mol Microbiol 18: 593–603.
8. Contag CH, Spilman SD, Contag PR, Oshiro M, Eames B, Dennery P, Stevenson DK, Benaron DA. 1997. Visualizing gene expression in living mammals using a bioluminescent reporter. Photochem Photobiol 66: 523–531.
9. Cook N, Olive KP, Frese K, Tuveson DA. 2008. K-Ras-driven pancreatic cancer mouse model for anticancer inhibitor analyses. Methods Enzymol 439: 73–85.
10. De Luca F, De Simone BC, Maraviglia B. 1982. Role of 3D imaging in small scale NMR tomography. Magn Reson Imaging 1: 205–208.
11. Fink C, Kiessling F, Bock M, Lichy MP, Misselwitz B, Peschke P, Fusenig NE, Grobholz R, Delorme S. 2003. High-resolution three-dimensional MR angiography of rodent tumors: Morphologic characterization of intratumoral vasculature. J Magn Reson Imaging 18: 59–65.
12. Gambhir SS. 2002. Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer 2: 683–693.
13. Gessner R, Dayton PA. 2010. Advances in molecular imaging with ultrasound. Mol Imaging 9: 117–127.
14. Goertz DE, Yu JL, Kerbel RS, Burns PN, Foster FS. 2002. High-frequency Doppler ultrasound monitors the effects of antivascular therapy on tumor blood flow. Cancer Res 62: 6371–6375.
15. Haberkorn U, Ziegler SI, Oberdorfer F, Trojan H, Haag D, Peschke P, Berger MR, Altmann A, van Kaick G. 1994. FDG uptake, tumor proliferation and expression of glycolysis associated genes in animal tumor models. Nucl Med Biol 21: 827–834.
16. Hansen G, Crooks LE, Davis P, De Groot J, Herfkens R, Margulis AR, Gooding C, Kaufman L, Hoenninger J, Arakawa M, et al. 1980. In vivo imaging of the rat anatomy with nuclear magnetic resonance. Radiology 136: 695–700.
17. Herneth AM, Guccione S, Bednarski M. 2003. Apparent diffusion coefficient: A quantitative parameter for in vivo tumor characterization. Eur J Radiol 45: 208–213.
18. Jordan BF, Runquist M, Raghunand N, Baker A, Williams R, Kirkpatrick L, Powis G, Gillies RJ. 2005. Dynamic contrast-enhanced and diffusion MRI show rapid and dramatic changes in tumor microenviron- ment in response to inhibition of HIF-1α using PX-478. Neoplasia 7: 475–485.
19. Kung AL. 2007. Practices and pitfalls of mouse cancer models in drug discovery. Adv Cancer Res 96: 191–212.
20. Leblond F, Davis SC, Valdes PA, Pogue BW. 2010. Pre-clinical whole-body fluorescence imaging: Review of instruments, methods and applications. J Photochem Photobiol B 98: 77–94.
21. Lyons SK, Patrick PS, Brindle KM. 2013. Imaging mouse cancer models in vivo using reporter transgenes. Cold Spring Harb Protoc doi: 10.1101/pdb.top069864
22. Macri MA, Casieri C, De Luca F, Maraviglia B, Belardelli F, Proietti E, Carpinelli G, Podo F. 1992. Spin-lattice relaxation in murine tumors after in vivo treatment with interferon alpha/beta or tumor necrosis factor alpha. Magn Reson Med 23: 12–20.
23. Maleke C, Konofagou EE. 2010. In vivo feasibility of real-time monitoring of focused ultrasound surgery (FUS) using harmonic motion imaging (HMI). IEEE Trans Biomed Eng 57: 7–11.
24. Maleke C, Luo J, Gamarnik V, Lu XL, Konofagou EE. 2010. Simulation study of amplitude-modulated (AM) harmonic motion imaging (HMI) for stiffness contrast quantification with experimental validation. Ultrason Imaging 32: 154–176.
25. Mori S, Crain BJ, Chacko VP, van Zijl PC. 1999. Three-dimensional tracking of axonal projections in the brain by magnetic resonance imaging. Ann Neurol 45: 265–269.
26. Olive KP, Politi K. 2014. Translational therapeutics in genetically engineered mouse models of cancer. Cold Spring Harb Protoc doi: 10.1101/pdb.top069997.
27. Olive KP, Tuveson DA. 2006. The use of targeted mouse models for preclinical testing of novel cancer therapeutics. Clin Cancer Res 12: 5277–5287.
28. Prescher JA, Contag CH. 2010. Guided by the light: Visualizing biomolecular processes in living animals with bioluminescence. Curr Opin Chem Biol 14: 80–89.
29. Raghunand N. 2006. Tissue pH measurement by magnetic resonance spectroscopy and imaging. Methods Mol Med 124: 347–364.
30. Safran M, Kim WY, Kung AL, Horner JW, DePinho RA, Kaelin WA Jr. 2003. Mouse reporter strain for noninvasive bioluminescent imaging of cells that have undergone Cre-mediated recombination. Mol Imaging 2: 297–302.
31. Sastra SA, Olive KP. 2013. Quantification of murine pancreatic tumors by high-resolution ultrasound. Methods Mol Biol 980: 249–266.
32. Schad LR, Brix G, Zuna I, Harle W, Lorenz WJ, Semmler W. 1989. Multiexponential proton spin-spin relaxation inMR imaging of human brain tumors. J Comput Assist Tomogr 13: 577–587.
33. Schmid A, Schmitz J, Mannheim JG, Maier FC, Fuchs K, Wehrl HF, Pichler BJ. 2012. Feasibility of sequential PET/MRI using a state-of-the-art small animal PET and a 1 T benchtop MRI. Mol Imaging Biol 15: 155–165.
34. Shoghi KI. 2009. Quantitative small animal PET. Q J Nucl Med Mol Imaging 53: 365–373.
35. Sun Y, Kung AL. 2014. Pre-clinical magnetic resonance imaging in mouse cancer models. Cold Spring Harb Protoc doi: 10.1101/pdb.prot078253.
36. Sun Y, Mulkern RV, Schmidt K, Doshi S, Albert MS, Schmidt NO, Ziu M, Black P, Carrol R, Kieran MW. 2004. Quantification of water diffusion and relaxation times of human U87 tumors in a mouse model. NMR Biomed 17: 399–404.
37. Szentirmai O, Baker CH, Lin N, Szucs S, Takahashi M, Kiryu S, Kung AL, Mulligan RC, Carter BS. 2006. Noninvasive bioluminescence imaging of luciferase expressing intracranial U87 xenografts: Correlation with magnetic resonance imaging determined tumor volume and longitudinal use in assessing tumor growth and antiangiogenic treatment effect. Neurosurgery 58: 365–372.
38. Talmadge JE, Singh RK, Fidler IJ, Raz A. 2007. Murine models to evaluate novel and conventional therapeutic strategies for cancer. Am J Pathol 170: 793–804.
39. Tam JM, Upadhyay R, Pittet MJ, Weissleder R, Mahmood U. 2007. Improved in vivo whole-animal detection limits of green fluorescent protein-expressing tumor lines by spectral fluorescence imaging. Mol Imaging 6: 269–276.
40. Tseng J-C, Kung AL. 2014. Quantitative bioluminescence imaging of mouse tumor models. Cold Spring Harb Protoc doi: 10.1101/pdb.prot078261
41. Vande Velde G, Baekelandt V, Dresselaers T, Himmelreich U. 2009. Magnetic resonance imaging and spectroscopy methods for molecular imaging. Q J Nucl Med Mol Imaging 53: 565–585.
42. Van den Abbeele AD. 2008. The lessons of GIST–PET and PET/CT: A new paradigm for imaging. Oncologist 13: 8–13.
43. Vanderheyden JL. 2009. The use of imaging in preclinical drug development. Q J Nucl Med Mol Imaging 53: 374–381.
44. Van Dyke T, Jacks T. 2002. Cancer modeling in the modern era: Progress and challenges. Cell 108: 135–144.
45. Wang Y, Kung AL. 2014. 18F-FDG-PET/CT imaging of drug-induced metabolic changes in genetically engineered mouse lung cancer models. Cold Spring Harb Protoc doi: 10.1101/pdb.prot078246
46. Weissleder R, Ntziachristos V. 2003. Shedding light onto live molecular targets. Nat Med 9: 123–128.
47. Weissleder R, Pittet MJ. 2008. Imaging in the era of molecular oncology. Nature 452: 580–589.
48. Willmann JK, Paulmurugan R, Chen K, Gheysens O, Rodriguez-Porcel M, Lutz AM, Chen IY, Chen X, Gambhir SS. 2008a. US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice. Radiology 246: 508–518.
49. Willmann JK, van Bruggen N, Dinkelborg LM, Gambhir SS. 2008b. Molecular imaging in drug development. Nat Rev Drug Discov 7: 591–607.
50. Zhao H, Doyle TC, Coquoz O, Kalish F, Rice BW, Contag CH. 2005. Emission spectra of bioluminescent reporters and interaction with mammalian tissue determine the sensitivity of detection in vivo. J Biomed Opt 10: 41210.
51. Zoula S, Herigault G, Ziegler A, Farion R, Decorps M, Remy C. 2003. Correlation between the occurrence of 1H-MRS lipid signal, necrosis and lipid droplets during C6 rat glioma development. NMR Biomed 16: 199–212.